Anthera Pharmaceuticals Net Income

Anthera Pharmaceuticals (ANTH) currently reports a net income of $-9.9M as of March 2018. That compares with $-56M in the prior-year period — up 82.2% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Anthera Pharmaceuticals's net income history and peer comparisons.

Anthera Pharmaceuticals's net income increased from $-56M to $-9.9M — a 82.2% year-over-year increase (period ending March 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anthera Pharmaceuticals's net income of $-9.9M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Anthera Pharmaceuticals reported $-9.9M in net income as of March 2018. That compares with $-56M in the prior-year period — up 82.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-9.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Anthera Pharmaceuticals, and consider following ANTH for alerts when major investors trade the stock.